Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00039130 Information provided by National Cancer Institute (NCI)

First Received: June 6, 2002 Last Updated: October 13, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)